Two-Year Outcomes of Sapropterin Treatment in Children with Phenylketonuria: A Longitudinal Observational Study of Metabolic, Dietary, and Psychosocial Effects
Nutrients · 2026
DOI: 10.3390/nu18030446 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nutrients, 2026. Verfasst von Ozlem Yilmaz Nas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Birmingham Women's and Children's Hospital, Birmingham B4 6NH, UK. Hauptthemen laut MEDLINE: Phenylketonurias, Biopterins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Society for Phenylketonuria (NSPKU).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Evidence on the long-term impact of sapropterin in phenylketonuria (PKU) is limited. Understanding its effects on dietary restrictions, growth in children, and caregiver burden is essential to optimize PKU management.
Methods
This prospective, two-year longitudinal study with a comparison group followed 33 children with PKU after sapropterin responsiveness assessment (21 responsive, 12 non-responsive). Outcomes included metabolic control, prescribed protein intake, dietary patterns, growth, psychological measures, and caregiver burden.
Results
Sapropterin-responsive children increased natural protein intake from 10 g to 28 g/day at 2 years (p < 0.001), with reduced protein substitute intake (60 g [56–63] to 45 g [40–60], p < 0.05); no changes occurred in non-responsive children (p > 0.05). Animal-based foods (cheese, eggs, meat, fish) were introduced in 52% (11/21) of responsive children once tolerance exceeded approximately 25 g/day. The caregivers of responsive children reported reduced financial, familial-social, and personal burden (all p ≤ 0.05), alongside decreased food neophobia (p = 0.005) and caregiver depression (p = 0.013). In sapropterin-responsive children, weight and BMI z-scores remained stable, while height z-score increased over 24 months (p = 0.03); non-responsive children had higher weight and BMI z-scores than responsive children at 24 months (p = 0.037 and p = 0.026). Blood phenylalanine concentrations remained within recommended target ranges overall, with lower median values in responsive children at several time points.
Conclusions
Sapropterin enabled more flexible, sustainable dietary management in responsive children with PKU, supporting metabolic control, growth, and improved family well-being and social participation. Equitable access to therapies and long-term dietetic support remain essential to optimize outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Birmingham Women's and Children's Hospital, Birmingham B4 6NH, UK.
- Department of Nutrition and Dietetics, Ankara Yildirim Beyazit University, Ankara 06760, Turkey.
ORCID-Profile: Ozlem Yilmaz Nas, Anne Daly, Sharon Evans, Yahya Ozdogan
Förderung
- National Society for Phenylketonuria (NSPKU)
Zitieren
APA
Yilmaz Nas, O., Ashmore, C., Gama, M. I., Daly, A., Evans, S., Pinto, A., Ozdogan, Y., & MacDonald, A. (2026). Two-Year Outcomes of Sapropterin Treatment in Children with Phenylketonuria: A Longitudinal Observational Study of Metabolic, Dietary, and Psychosocial Effects. Nutrients. https://doi.org/10.3390/nu18030446
Vancouver
Yilmaz Nas O, Ashmore C, Gama MI, Daly A, Evans S, Pinto A, et al. Two-Year Outcomes of Sapropterin Treatment in Children with Phenylketonuria: A Longitudinal Observational Study of Metabolic, Dietary, and Psychosocial Effects. Nutrients. 2026. doi:10.3390/nu18030446
BibTeX
@article{YilmazNas2026,
author = {Yilmaz Nas, Ozlem and Ashmore, Catherine and Gama, Maria Ines and Daly, Anne and Evans, Sharon and Pinto, Alex and Ozdogan, Yahya and MacDonald, Anita},
title = {Two-Year Outcomes of Sapropterin Treatment in Children with Phenylketonuria: A Longitudinal Observational Study of Metabolic, Dietary, and Psychosocial Effects},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18030446}
}
EUVIMED